Minerva Neurosciences to Participate in The Citizens Life Sciences Conference

Rhea-AI Summary

Minerva Neurosciences (Nasdaq: NERV) announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will present at The Citizens Life Sciences Conference in Miami on March 10-11, 2026.

The company will deliver a company presentation on Tuesday, March 10 at 9:35 AM ET; a live webcast and a replay available for ninety days will be provided, according to the company.

Key Figures

Conference dates: March 10–11, 2026 Presentation time: 9:35 AM ET Replay availability: 90 days

3 metrics

Conference dates March 10–11, 2026 The Citizens Life Sciences Conference in Miami, FL

Presentation time 9:35 AM ET Company presentation on Tuesday, March 10, 2026

Replay availability 90 days Webcast replay on Investors & Media Events webpage

Market Reality Check

Price: $6.86 Vol: Volume 143,727 is 20% abo...

normal vol

$6.86 Last Close

Volume Volume 143,727 is 20% above 20-day average 120,105 ahead of a neutral conference appearance. normal

Technical Shares are trading above the 200-day MA at $3.15, while the stock sits 44.94% below its 52-week high and well above its 52-week low.

Peers on Argus

Peer moves are mixed, with names like BIVI up 6.2% and PRTG down 10.39%, while o...

1 Down

Peer moves are mixed, with names like BIVI up 6.2% and PRTG down 10.39%, while only one peer (BCTX) appears on the momentum scanner moving down, suggesting today’s conference participation reads as company-specific rather than a broad sector move.

Historical Context

4 past events · Latest: 2026-01-26 (Positive)

Pattern 4 events

Date	Event	Sentiment	Move	Catalyst
2026-01-26	KOL event announcement	Positive	+2.5%	Announced virtual KOL event on roluperidone and planned 2026 Phase 3 trial.
2025-11-19	Board and financing update	Positive	+0.0%	Appointed new director and highlighted private placement up to $200 million.
2025-11-05	Q3 2025 results	Positive	+4.1%	Reported Q3 2025 results and detailed $80M upfront plus additional warrant funding.
2025-10-21	Phase 3 financing	Positive	+141.0%	Announced financing of up to $200M to fund Phase 3, NDA resubmission, launch prep.

Pattern Detected

Recent news on financing, clinical planning, and events has generally aligned with positive or flat next-day price reactions, including a very strong move on the major October 2025 financing update.

Recent Company History

Over the past several months, Minerva has focused on financing and clinical execution for roluperidone. In October 2025, it announced financing of up to $200 million tied to a confirmatory Phase 3 trial and NDA resubmission, which saw a 140.98% next-day move. Subsequent Q3 2025 results and an October private placement update were associated with a $80 million upfront raise and modestly positive reaction. A January 2026 KOL event announcement also drew a positive response. Today’s conference participation fits within this cadence of ongoing investor and scientific outreach.

Market Pulse Summary

This announcement highlights Minerva’s participation in an investor-focused life sciences conference...

Analysis

This announcement highlights Minerva’s participation in an investor-focused life sciences conference on March 10–11, 2026, offering additional visibility for its CNS pipeline and roluperidone program. It follows recent financing and clinical-planning milestones that supported a confirmatory Phase 3 trial and NDA resubmission plans. Investors may track upcoming Phase 3 trial initiation, regulatory interactions, and future data readouts as more material catalysts compared with routine conference appearances.

AI-generated analysis. Not financial advice.

BURLINGTON, Mass., March 04, 2026 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today announced that Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate in The Citizens Life Sciences Conference being held March 10-11, 2026 in Miami, FL.

The Citizens Life Sciences Conference
Format:	Company presentation
Day/Time:	Tuesday, March 10 at 9:35 AM ET
Webcast:	https://event.summitcast.com/view/BuMiPNPtyHKimMF6k4AFMd/SKrutqyvQVtnaKJDseE6uU

If you are interested in meeting with the Minerva team during the conference, please reach out to your Citizens Bank representative.

A replay of the presentation will be available on the Company's Investors & Media Events and Presentations webpage for ninety days following the event.

About Minerva Neurosciences

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing product candidates to treat CNS diseases. Minerva is initiating a confirmatory Phase 3 trial with roluperidone for negative symptoms of schizophrenia. For more information, please visit the Company’s website.

Contacts:
Investor inquiries:

Frederick Ahlholm
Chief Financial Officer
Minerva Neurosciences, Inc.
FAhlholm@minervaneurosciences.com

Corey Davis, Ph.D.
LifeSci Advisors, LLC
212-915-2577
cdavis@lifesciadvisors.com

FAQ

When will Minerva Neurosciences (NERV) present at The Citizens Life Sciences Conference?

Minerva will present on Tuesday, March 10, 2026 at 9:35 AM ET. According to Minerva Neurosciences, the presentation is a company presentation during the March 10-11 conference in Miami with a live webcast link provided.

How can investors watch the Minerva Neurosciences (NERV) presentation webcast on March 10, 2026?

Investors can watch via the live webcast link provided by the conference. According to Minerva Neurosciences, the company supplied a webcast URL and will post a replay on its Investors & Media Events and Presentations webpage.

Will Minerva Neurosciences (NERV) make a replay of the March 10, 2026 presentation available?

Yes. A replay will be available for ninety days following the event. According to Minerva Neurosciences, the replay will be posted on the company's Investors & Media Events and Presentations webpage for 90 days.

Who from Minerva Neurosciences (NERV) will speak at The Citizens Life Sciences Conference?

Remy Luthringer, PhD, Executive Chairman & Chief Executive Officer, will participate and present. According to Minerva Neurosciences, he will represent the company during the March 10 company presentation in Miami.

Can shareholders request a meeting with Minerva Neurosciences (NERV) at the March 10-11, 2026 conference?

Yes. Interested parties should contact their Citizens Bank representative to request a meeting. According to Minerva Neurosciences, meeting requests are coordinated through Citizens Bank for conference attendees.

Where will details about Minerva Neurosciences' (NERV) conference presentation be posted after March 10, 2026?

Presentation details and the replay will be posted on the company's investor events page. According to Minerva Neurosciences, the replay and related presentation materials will be available on its Investors & Media Events and Presentations webpage for 90 days.